These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion. Kuo KT, Chang HC, Hsiao CH, Lin MC. Br J Ophthalmol; 2006 Jul; 90(7):894-9. PubMed ID: 16540490 [Abstract] [Full Text] [Related]
23. [Cervical glandular intraepithelial neoplasia: a clinicopathologic and immunohistochemical analysis of 80 cases]. Luo R, Chen XD, Zhu LY. Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):32-6. PubMed ID: 23611270 [Abstract] [Full Text] [Related]
24. Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Litvinov SV, van Driel W, van Rhijn CM, Bakker HA, van Krieken H, Fleuren GJ, Warnaar SO. Am J Pathol; 1996 Mar; 148(3):865-75. PubMed ID: 8774141 [Abstract] [Full Text] [Related]
25. Proliferation in the normal cervix and in preinvasive cervical lesions. Payne S, Kernohan NM, Walker F. J Clin Pathol; 1996 Aug; 49(8):667-71. PubMed ID: 8881920 [Abstract] [Full Text] [Related]
26. Histopathological study of the spreading neoplastic cells in cervical glands and surface epithelia in cervical intra-epithelial neoplasia and microinvasive squamous cell carcinoma: Ki-67 immunostaining is a useful marker for pathological diagnosis from the gland involvement site. Kimura M, Matsumoto T, Morizane T, Sonoue H, Ogishima D, Kinoshita K. Pathol Int; 2006 Aug; 56(8):428-33. PubMed ID: 16872436 [Abstract] [Full Text] [Related]
27. An immunohistochemical study of p53 protein in cervical intraepithelial neoplasia and squamous cell carcinoma. Raju GC, Teh M, Wee A. Pathology; 1996 Jan; 28(1):17-19. PubMed ID: 8714263 [Abstract] [Full Text] [Related]
28. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix. Bonds L, Baker P, Gup C, Shroyer KR. Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751 [Abstract] [Full Text] [Related]
29. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions. Dimitrakakis C, Kymionis G, Diakomanolis E, Papaspyrou I, Rodolakis A, Arzimanoglou I, Leandros E, Michalas S. Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702 [Abstract] [Full Text] [Related]
30. [Aspects of Bcl-2 proto-oncogene expression in dysplastic and malignant lesions of the uterine cervix]. Borţun F, Chiovschi S, Moldovan M. Rev Med Chir Soc Med Nat Iasi; 2004 Apr; 108(4):821-6. PubMed ID: 16004225 [Abstract] [Full Text] [Related]
31. Ki-67 labelling as a proliferation marker in pre-invasive squamous epithelial lesions of cervix. Pahuja S, Choudhury M, Gupta U. Indian J Pathol Microbiol; 2003 Jul; 46(3):402-4. PubMed ID: 15025284 [Abstract] [Full Text] [Related]
32. Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat. Xie W, Wong YC, Tsao SW. Prostate; 2000 Jun 15; 44(1):31-9. PubMed ID: 10861755 [Abstract] [Full Text] [Related]
33. Fascin expression in cervical normal squamous epithelium, cervical intraepithelial neoplasia, and superficially invasive (stage IA1) squamous carcinoma of the cervix. Koay MH, Crook M, Stewart CJ. Pathology; 2014 Aug 15; 46(5):433-8. PubMed ID: 24977742 [Abstract] [Full Text] [Related]
34. Expressions of survivin, P16(INK4a), COX-2, and Ki-67 in cervical cancer progression reveal the potential clinical application. Zhou WQ, Sheng QY, Sheng YH, Hou WJ, Xu GX, Wu YM, Lu H. Eur J Gynaecol Oncol; 2015 Aug 15; 36(1):62-8. PubMed ID: 25872337 [Abstract] [Full Text] [Related]
35. Expression of the p53 homologue p63 in early cervical neoplasia. Quade BJ, Yang A, Wang Y, Sun D, Park J, Sheets EE, Cviko A, Federschneider JM, Peters R, McKeon FD, Crum CP. Gynecol Oncol; 2001 Jan 15; 80(1):24-9. PubMed ID: 11136565 [Abstract] [Full Text] [Related]
36. Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis. Qiao X, Bhuiya TA, Spitzer M. J Low Genit Tract Dis; 2005 Apr 15; 9(2):100-7. PubMed ID: 15870531 [Abstract] [Full Text] [Related]
37. Relevance of the rates of PCNA, Ki-67 and p53 expression according to the epithelial compartment in cervical lesions. Maeda MY, Simões M, Wakamatsu A, Longatto Filho AL, Oyafuso M, de Mello ES, Otta MM, Alves VA. Pathologica; 2001 Jun 15; 93(3):189-95. PubMed ID: 11433611 [Abstract] [Full Text] [Related]
38. Can keratin 8 and 17 immunohistochemistry be of diagnostic value in cervical cytology? A feasibility study. Martens J, Baars J, Smedts F, Holterheus M, Kok MJ, Vooijs P, Ramaekers F. Cancer; 1999 Apr 25; 87(2):87-92. PubMed ID: 10227599 [Abstract] [Full Text] [Related]
39. Immunohistochemical expression of p16, Ki-67 and p53 in cervical lesions - A systematic review. Silva DC, Gonçalves AK, Cobucci RN, Mendonça RC, Lima PH, Cavalcanti G. Pathol Res Pract; 2017 Jul 25; 213(7):723-729. PubMed ID: 28554769 [Abstract] [Full Text] [Related]
40. Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix. Kanai M, Shiozawa T, Xin L, Nikaido T, Fujii S. Cancer; 1998 May 01; 82(9):1709-19. PubMed ID: 9576293 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]